Grigorios Panagiotou

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Mitochondrial Dna

Ejection Fraction

Coronavirus Disease

Top Venues

Endocrine reviews

Clinical endocrinology

International journal of endocrinology

Beth Israel Deaconess Medical Center

Aristotle University of Thessaloniki School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Beth Israel Deaconess Medical Center

United States

Research Fellow :: Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine

Education History

Aristotle University of Thessaloniki School of Medicine Apr 30 2015

Greece

PHD :: Laboratory of Pharmacology

Publications

Yi Shiau Ng, Albert Zishen Lim, Grigorios Panagiotou, Doug M Turnbull, Mark Walker
Endocrine Manifestations and New Developments in Mitochondrial Disease. Endocrine reviews 43 (3) (2022)
Yi Shiau Ng, Albert Zishen Lim, Grigorios Panagiotou, Doug M Turnbull, Mark Walker
Endocrine manifestations and new developments in mitochondrial disease. Endocrine reviews (2021)
Grigorios Panagiotou, Sofia Triantafyllidou, Basil C Tarlatzis, Eleni Papakonstantinou
Serum Levels of Irisin and Omentin-1 in Breast Neoplasms and Their Association with Tumor Histology. International journal of endocrinology 2021 (2021)
Grigorios Panagiotou, Su Ann Tee, Yasir Ihsan, Waseem Athar, Gabriella Marchitelli, Donna Kelly, Christopher S Boot, Nadia Stock, James Macfarlane, Adrian R Martineau, Graham P Burns, Richard Quinton
Original publication: Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clinical endocrinology 93 (5) (2020)
Grigorios Panagiotou, Su Ann Tee, Yasir Ihsan, Waseem Athar, Gabriella Marchitelli, Donna Kelly, Christopher S Boot, Nadia Stock, James Macfarlane, Adrian R Martineau, Graham Burns, Richard Quinton
Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clinical endocrinology 93 (4) (2020)